News Daily News Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD Michael O'Riordan March 06, 2025
News Daily News Aspirin Use for Primary Prevention Declining in US: NHANES Michael O'Riordan January 24, 2025
News Daily News Absence of CAC May be Protective Even in Patients With Very High Cholesterol Michael O'Riordan February 14, 2022
News Daily News New Chest Pain Guidelines Out at Last: Most Tests Have a Role Michael O'Riordan October 28, 2021
News Daily News Experts Fear Coronary CT Advice for Patients Misses the Mark Michael O'Riordan March 19, 2021
News Daily News CAC Screening Cost-effective for Statin Decisions in Hereditary CAD Michael O'Riordan January 14, 2021
News Daily News CAC Testing Improves Pretest Probability of Obstructive CAD Michael O'Riordan November 23, 2020
News Daily News Coronary Calcium Scans May ID Patients Who Benefit From Aspirin Michael O'Riordan October 30, 2020
News Daily News Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals Michael O'Riordan January 16, 2020
News Daily News New Review Questions Statin Benefit in Lower-Risk Primary Prevention Patients Michael O'Riordan October 22, 2019
News Daily News Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy Michael O'Riordan October 25, 2018
News Daily News USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment Michael O'Riordan July 12, 2018
News Daily News ‘Nontraditional’ CAC, CRP, or ABI Risk Tools Not Recommended, Says USPSTF Shelley Wood January 17, 2018
News Daily News La Angiografía por TC a la Vanguardia en la Valoración del Dolor Torácico en el Reino Unido Michael O'Riordan December 07, 2016
News Daily News CT Angiography Moves to Forefront in Assessment of Chest Pain in UK Michael O'Riordan December 07, 2016
News Daily News Many Guidelines, Mixed Consensus: Different CVD Risk Guidelines Cause Confusion in Practice Michael O'Riordan September 16, 2016
News Daily News Demasiados Elementos en Juego: La Existencia de Diferentes y Discordantes Directrices Hace que la Valoración del Riesgo de ECV sea Confusa Michael O'Riordan September 16, 2016